Welcome to our dedicated page for Piper Sandler Co`S news (Ticker: PIPR), a resource for investors and traders seeking the latest updates and insights on Piper Sandler Co`S stock.
Piper Sandler Companies (NYSE: PIPR) is an investment bank and institutional securities firm whose news flow reflects its advisory, capital markets and institutional businesses. Company updates frequently cover financial results, leadership changes, sector team expansions and strategic initiatives that affect its investment banking and securities platforms.
Recent announcements include schedules for quarterly and full-year earnings releases and related conference calls, where the firm discusses its financial performance with investors and analysts. These events are typically accompanied by Form 8-K filings referencing results of operations and financial condition, and by press releases made available through the company’s channels.
Piper Sandler also issues news about its investment banking teams and product capabilities. Examples include the addition of senior bankers in healthcare investment banking and financial services investment banking, the elevation of new co-heads in healthcare, consumer investment banking and equity capital markets, and leadership appointments in fixed income. The firm has announced the launch of private markets trading focused on equity shares of private companies, as well as a definitive agreement to acquire MENA Growth Partners to create a strategic investment banking hub in the GCC region.
Investors, clients and market observers following PIPR news can use this page to track developments across advisory, capital markets, private markets trading, fixed income and geographic expansion. Regular updates on earnings, senior hires, leadership roles and strategic transactions provide insight into how Piper Sandler is positioning its investment banking and institutional securities businesses.
Piper Sandler (NYSE: PIPR) appointed Aamer Naseer as global head of life sciences outsourcing and B2B med tech, effective immediately as announced February 25, 2026.
Naseer brings 25 years of sector experience advising public and private medical device, manufacturing and outsourcing clients, positioned to expand the firm’s capabilities in life sciences outsourcing and B2B med tech.
Piper Sandler (NYSE: PIPR) hired Jason Arnold as a managing director in its healthcare investment banking group, based initially in London while serving global clients. Arnold will advise life science tools and diagnostics companies on M&A, strategic partnerships and capital raising, bringing 16 years of sector experience.
Previously a partner and managing director at William Blair, Arnold began his career at Ernst & Young and holds a bachelor’s and master’s from the University of Colorado, Boulder.
Piper Sandler (NYSE: PIPR) reported fourth quarter and full year 2025 results and announced a $5.00 per share special dividend, a $0.70 per share quarterly dividend, and a 4-for-1 stock split. The company will host an earnings conference call on Feb 6, 2026 at 7:00 a.m. CT with webcast and playback available on its investor website. Dial-in numbers and passcode were provided for live participation.
Piper Sandler (NYSE: PIPR) appointed Stuart M. Essig, Ph.D., to its board of directors effective February 4, 2026. Essig brings extensive healthcare and medical-technology experience, including prior roles as CEO, chairman and executive chairman of Integra LifeSciences and senior M&A experience at Goldman Sachs.
During his tenure at Integra, revenues grew from about $15 million to more than $1.6 billion. Essig also serves on the board of IDEXX Laboratories and previously served on boards including St. Jude Medical, Zimmer Biomet, Owens & Minor, and Orthofix.
Piper Sandler (NYSE: PIPR) announced the hire of Tim Carlson as managing director on its energy & power investment banking team, with a focus on upstream.
Carlson brings over 28 years of investment banking experience and has advised on more than 165 transactions totaling over $125 billion. He joins from Intrepid Partners and previously held senior roles at Evercore, JPMorgan and Bank of America Merrill Lynch.
Piper Sandler (NYSE: PIPR) completed the acquisition of MENA Growth Partners, a Abu Dhabi-based merchant bank that will serve as Piper Sandler's strategic investment banking hub in the GCC region.
Nabeel Siddiqui, currently a managing director in Piper Sandler's London office, will relocate to Abu Dhabi to lead the firm's regional investment banking while retaining responsibilities for his European business. The acquisition is intended to link Piper Sandler's expertise in energy, infrastructure, chemicals, healthcare, technology, equity capital markets and private capital advisory with MENA Growth Partners' regional relationships. Legal advisers on the deal included Al Tamimi & Company for Piper Sandler and Charles Russell Speechlys and TMF Group for MENA Growth Partners.
Piper Sandler (NYSE: PIPR) will release its fourth quarter and full year 2025 financial results before market open on Friday, February 6, 2026. Management will host a conference call the same day at 8:00 a.m. ET (7:00 a.m. CT) with a Q&A session. Investors can join by phone (U.S. 800 330-6710; international +1 312 471-1353; passcode 3387875) or via a live audio webcast at pipersandler.com/earnings. A replay will be available on the same webpage. For access questions, contact Piper Sandler Investor Relations at investorrelations@psc.com.
Piper Sandler (NYSE: PIPR) announced the hire of Dan Wolf as a managing director in its healthcare investment banking group, based in Minneapolis, effective January 12, 2026. Wolf will advise healthcare technology companies on mergers & acquisitions, strategic partnerships and capital raising. He returns to Piper Sandler after 20+ years in healthcare, including roles as CFO at Theradaptive, SVP and chief strategy officer at Baxter, and senior leadership at Medtronic. His background includes degrees from Bowdoin, MIT and Harvard Business School.
Piper Sandler (NYSE: PIPR) announced leadership changes across its investment banking and equity capital markets teams on January 6, 2026. The firm elevated Brandon Rice and Chad Huber as co-heads of healthcare investment banking alongside Peter Day; named Carlos Sanchez co-head of consumer investment banking alongside Damon Chandik and Janica Lane; and promoted Paul Scansaroli to global co-head of equity capital markets alongside David Stadinski. The appointments emphasize the firm’s focus on scaling capabilities, deepening client relationships, and supporting M&A and equity transactions for healthcare and consumer sectors.
Piper Sandler (NYSE: PIPR) named J.P. Peltier global co-head of investment banking and capital markets, effective January 5, 2026. He will serve alongside James Baker and Mike Dillahunt.
Peltier most recently served as global head of healthcare investment banking, where he led a team of more than 145 investment banking professionals across the U.S., Europe and Asia. He joined Piper Sandler in 1994 and will remain active in growing the firm's healthcare practice while supporting other industry groups.